Clinical Trials Sponsored by Beijing pediatric research institute

Total 255 results

Capital Research Institute of Pediatrics

Unknown

Ruxolitinib Combined With Dexamethasone for HLH

Hemophagocytic Lymphohistiocytosis

China
Capital Research Institute of Pediatrics

Unknown

Modified Post-Transplant Cyclophosphamide Regimen for Children With Juvenile Myelomonocytic Leukemia

Hematopoietic System--Cancer
Capital Research Institute of Pediatrics

Unknown

Improved Post-Transplant Cyclophosphamide Regimens for Pediatric Patients With Refractory AML

Hematopoietic System--Cancer

China
Capital Research Institute of Pediatrics

Unknown

Post-transplant Cyclophosphamide in Wiskott-Aldrich Syndrome

Wiskott-Aldrich Syndrome
Otsuka Beijing Research Institute

Recruiting

PK/Efficacy Bridging Study of ASTX727 in Chinese Subjects With Myelodysplastic Syndromes

Myelodysplastic Syndromes

China
Otsuka Beijing Research Institute

Active, not recruiting

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

Acute Lymphoblastic Leukemia | Chronic Myeloid Leukemia

China
Otsuka Beijing Research Institute

Completed

OPC-61815 in Healthy Chinese Male Subjects

Healthy Adult Male

China
Otsuka Beijing Research Institute

Terminated

The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder

Major Depressive Disorder

China
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot in the Acute Treatment of Adults With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

PK Study of Aripiprazole IM Depot for Chinese Patients With Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Unknown

To Compare the Effect of Concomitant Administration of Probucol and Cilostazol With Probucol Single Treatment on the Atherosclerosis Related Markers (Including the Thickness of the Achilles Tendon) and Evaluate Safety (Based on Atorvastatin Treatment) in Severe Hypercholesterolemia Subject

Severe Hypercholesterolemia

China
Otsuka Beijing Research Institute

Completed

Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid Tumors

Malignant Solid Tumour

Singapore
Otsuka Beijing Research Institute

Completed

Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects

Healthy

China
Otsuka Beijing Research Institute

Completed

Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia

Hyperlipidemia

China
Otsuka Beijing Research Institute

Completed

A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

Diabetic Nephropathy

China
Otsuka Beijing Research Institute

Completed

Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (0.3% and 1% OPA-15406 Ointment) Versus the Vehicle in Pediatric Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Beijing Research Institute

Recruiting

OPC-1085EL in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension in Chinese Subjects

Open Angle Glaucoma or Ocular Hypertension

China
Otsuka Beijing Research Institute

Completed

The Pharmacokinetics, and Safety of Brexpiprazole Tablets in Chinese Healthy Subjects

Healthy

China
Otsuka Beijing Research Institute

Completed

Safety and Efficacy of Brexpiprazole in the Treatment of Schizophrenia

Schizophrenia

China
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Tourette's Syndrome

Tourette Syndrome

China
Otsuka Beijing Research Institute

Completed

Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac Edema

Cardiac Edema

China
Otsuka Beijing Research Institute

Completed

Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject

Atherosclerosis Cerebral Infarction

China
Otsuka Beijing Research Institute

Recruiting

Phase II Clinical Trial of OPS-2071 in the Treatment of Irritable Bowel Syndrome of Diarrhea Type

Irritable Bowel Syndrome of Diarrhea Type (IBS-D)

China
Otsuka Beijing Research Institute

Recruiting

To Demonstrate the Superiority of IMP (1% OPA-15406 Ointment) to the Vehicle in Adult Patients With AD

Atopic Dermatitis (AD)

China
Otsuka Beijing Research Institute

Completed

The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects

Health

China
Otsuka Beijing Research Institute

Completed

Aripiprazole Oral Solution in the Treatment of Children and Adolescents With Autistic Disorder

Autistic Disorder

China
Otsuka Beijing Research Institute

Completed

A Bioequivalence Study Comparing a Single Oral Intake of an Imported PROBUCOL Tablet(Lorelco) With a Marketed PROBUCOL Tablet(Chang Tai) in Chinese Healthy Volunteers

Chinese Healthy Volunteers

China
Otsuka Beijing Research Institute

Completed

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

Ascites | Hepatic Cirrhosis

China
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Type 2 Diabetes Mellitus | Arteriosclerosis Obliterans

China
Beijing Jishuitan Hospital
National Institute for Nutrition and Health Chinese Center for Disease Control... and other collaborators

Completed

Bone Age of Chinese Child (BACC) (BACC)

Bone Development

China
Geriatric Education and Research Institute

Completed

The Effects of Functional Power Training on Frail and Pre-frail Community - Dwelling Older Adults in Singapore

Muscle Weakness | Frailty

Singapore
Beijing Tongren Hospital
Beijing Children's Hospital; Children's Hospital of The Capital Institute of...

Recruiting

650nm Low-level Red-light for Myopia Control and Prevention in Children

Myopia

China
Beijing Sanyuan Foods Co Ltd
Peking University; Beijing Ditan Hospital; Capital Institute of Pediatrics, China

Unknown

Short and Long Term Effect of Early Infant Feeding and Nutritional Status on the Children's Health

Health Behavior

China
Beijing Children's Hospital
Shenzhen Children's Hospital; Capital Institute of Pediatrics, China

Unknown

Pediatric Primary Immunodeficiency Disease (PID) in China

Primary Immunodeficiency Disease
Arkansas Children's Hospital Research Institute
Pediatric Pharmacology Research Units Network

Completed

Ambulatory Blood Pressure Monitoring in Hypertension

Hypertension

United States
Federal Research Institute of Pediatric Hematology...

Recruiting

Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome

Nijmegen Breakage Syndrome

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

PTCy and and Ruxolitinib for GVHD Prophylaxis After HSCT With Thymoglobulin in Conditioning Regimen in Patients With Inborn Errors of Immunity

Inborn Errors of Immunity

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Evaluation of Subcutaneous Immunoglobulin Product Cutaquig in Terms of Safety and Efficacy in the Treatment of Patients With Primary Immunodeficiencies

Primary Immunodeficiency Diseases (PID)

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021

Burkitt Lymphoma | Diffuse Large B-cell Lymphoma | Primary CNS Lymphoma | Primary Mediastinal Lymphoma | Non-hodgkin Lymphoma,B Cell

Russian Federation
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)

Acute Lymphoblastic Leukemia, Pediatric | ALL, Infants
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Total Lymphoid Irradiation Pre-HSCT in Severe Congenital Neutropenia

Severe Congenital Neutropenia | GATA2 Deficiency

Russian Federation
Federal Research Institute of Pediatric Hematology...

Not yet recruiting

Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT) (FMT-HSCT)

Antibiotic Resistant Strain

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome

Nijmegen Breakage Syndrome

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Efficacy and Safety of Romiplostim Versus Eltrombopag in the Treatment of Thrombocytopenia in Patients With Wiskott-Aldrich Syndrome

Wiskott-Aldrich Syndrome

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Brentuximab Vedotin as Alternative to the Autologous Stem Cell Transplantation in Relapsed and Refractory Classical Hodgkin's Lymphoma (BASALT) (BASALT)

Hodgkin's Lymphoma

Russian Federation
Federal Research Institute of Pediatric Hematology...

Recruiting

Eltrombopag+hATG+CsA vs. hATG+CsA in Children With Severe AA

Acquired Aplastic Anemia

Russian Federation
Federal Research Institute of Pediatric Hematology...

Active, not recruiting

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Myelodysplastic Syndromes | Juvenile Myelomonocytic Leukemia | Acute Lymphoblastic Leukemia | Myeloblastic Leukemia | Malignant Lymphoma | Biphenotypic Acute Leukemia

Russian Federation

Clinical Trials Sponsored by Beijing pediatric research institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations